Yun Fei (筠菲)筠菲
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 沈阳新马药业有限公司Chinese legal name: 沈阳新马药业有限公司
主要成分Active Ingredients
- 氟罗沙星Fuluo Shaxing
药物知识说明
氟罗沙星是一种在国家药监局注册认定的药品。该药品含有氟罗沙星-f87d6279等成分。
该药品关联的活性成分包括:氟罗沙星Fuluo Shaxing。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为:沈阳新马药业有限公司Chinese legal name: 沈阳新马药业有限公司。
您可以探索含有相同成分的其他药品:氟罗沙星-f87d6279成分药品。
本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 筠菲) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 氟罗沙星Fuluo Shaxing.
Manufacturers recorded for this product: 沈阳新马药业有限公司Chinese legal name: 沈阳新马药业有限公司.
Explore other medicines containing the same ingredient: 氟罗沙星 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 筠菲Recorded Chinese name: 筠菲
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 0.1g。0.1 g
本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 沈阳新马药业有限公司Chinese legal name: 沈阳新马药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20010601
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20010601
Manufacturer
Chinese legal name: 沈阳新马药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20010601
生产企业
沈阳新马药业有限公司(国产)
适应症
本品属氟喹诺酮类抗菌药物,适用于肠杆菌科细菌如肺炎克雷伯杆菌、变形杆菌、沙门氏菌、大肠埃希氏菌、甲氧西林敏感葡萄球菌等敏感菌引起的中、重度呼吸系统、泌尿系统、消化系统以及皮肤软组织感染、败血症、妇科感染等。
用法用量
避光静脉缓慢滴注,成人每次0.2-0.4g,加入5%葡萄糖溶液250ml中静滴,每日一次,或遵医嘱。
不良反应
1.常见的不良反应为胃肠道反应,如:恶心、呕吐、腹泻、便秘,其次为中枢神经系统反应,表现为失眠、头痛、头晕、烦燥等。|2.亦可引起皮肤光过敏、静脉炎、皮疹、皮肤瘙痒、心慌、痉挛、迷失方向及幻觉等,程度大多轻微。
禁忌
对本品或喹诺酮类药物过敏的患者、孕妇、哺乳期妇女?18岁以下患者及癫痫患者禁用。
注意事项
1.本品忌与生理盐水或葡萄糖盐水并用。|2.明显肝肾功能损害者慎用。|3.本品不宜与其他药物混合使用。|4.本品静脉滴注速度不宜过快,每l00ml滴注时间至少为 45 - 60分钟。|5.在治疗过程中以及最后一次用药三天之内,避免阳光浴和人工紫外线照射。
贮藏
避光、密闭保存。
规格
0.1g。
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.